Table 4

Multiple linear regression analysis of change scores for all patients

VariableSPL after 12 months‡EKD after 12 months‡BKD after 12 months‡PCS after 12 months‡MCS after 12 months‡
BCIBCIBCIBCIBCI
Gender, male (Ref)11.43*1.79 to 21.087.61−4.66 to 19.8811.49−4.33 to 27.338.12*2.96 to 13.254.87−0.65 to 10.39
Age group (Ref <67 years)
 >67 years−6.84−16.23 to 2.55−8.07−20.25 to 4.11−11.09−26.81 to 4.641.98−3.16 to 7.12−3.23−8.76 to 2.28
CKD, Stage 3a (Ref)
 Stage 3b0.99−11.42 to 21.082.50−13.86 to 18.85−5.72−26.28 to 14.85−1.64−8.66 to 5.380.98−6.55 to 8.51
 Stage 45.87−8.03 to 19.7815.91−1.81 to 33.645.06−17.63 to 27.751.36−6.47 to 9.191.58−6.82 to 9.98
 Stage 514.77−0.08 to 29.6221.41*2.49 to 40.3337.67*12.94 to 62.395.36−2.86 to 13.589.34*0.52 to 18.16
Diabetes duration (years)0.01−0.51 to 0.530.32−0.36 to 1.000.32−0.54 to 1.17−0.25−0.53 to 0.03−0.02−0.32 to 0.28
SES, Quintile 5† (Ref)
 Quintile 4−10.83−36.32 to 14.65−3.10−37.20 to 31.00−17.08−58.11 to 23.953.27−10.10 to 16.638.74−5.59 to 23.08
 Quintile 3−15.19−39.58 to 9.215.06−27.67 to 37.80−7.17−46.07 to 31.724.21−8.44 to 16.866.51−7.06 to 20.09
 Quintile 2−14.75−43.52 to 14.03−5.54−43.27 to 32.18−12.70−59.32 to 33.926.35−8.81 to 21.52−1.07−17.33 to 15.20
 Quintile 1−3.39−27.47 to 20.700.23−32.24 to 32.18−17.15−55.52 to 21.227.26−5.25 to 19.788.74−4.69 to 22.16
  • *P<0.05.

  • †Quintile 1 (had individuals from the most disadvantaged areas).

  • ‡Change score.

  • B, beta coefficient; BKD, burden of kidney disease; CKD, chronic kidney disease; EKD, effect of kidney disease; MCS, mental composite summary; PCS, physical composite summary; Ref, reference group; SES, socioeconomic status; SPL, symptom problem list.